Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury

Science Translational Medicine

Volumn 8, Issue 331, 2016, Pages

  Alidori, Simone ^a   Akhavein, Nima ^a   Thorek, Daniel L J ^b   Behling, Katja ^a   Romin, Yevgeniy ^a   Queen, Dawn ^a   Beattie, Bradley J ^a   Manova Todorova, Katia ^a   Bergkvist, Magnus ^c   Scheinberg, David A ^a,d   McDevitt, Michael R ^a,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBE; PROTEIN P53; SMALL INTERFERING RNA; CISPLATIN; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; MEPRIN; METALLOPROTEINASE; NANOFIBER;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CTR1 GENE; EGFP GENE; FEMALE; GENE; GENE SILENCING; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MEP1B GENE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TRP53 GENE; ACUTE KIDNEY INJURY; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; FIBROSIS; GENETICS; HELA CELL LINE; HUMAN; KIDNEY CORTEX; KINETICS; METABOLISM; PATHOLOGY; RNA TRANSPORT; ULTRASTRUCTURE;

ACUTE KIDNEY INJURY; ANIMALS; CISPLATIN; FEMALE; FIBROSIS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; KIDNEY CORTEX; KINETICS; METALLOENDOPEPTIDASES; MICE, INBRED BALB C; MICE, INBRED C57BL; NANOFIBERS; NANOTUBES, CARBON; RNA INTERFERENCE; RNA TRANSPORT; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84961779115     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aac9647     Document Type: Article

References (41)

1. D. Castanotto, J. J. Rossi, The promises and pitfalls of RNA-interference-based therapeutics. Nature 457, 426-433 (2009).
2. R. Kanasty, J. R. Dorkin, A. Vegas, D. Anderson, Delivery materials for siRNA therapeutics. Nat. Mater. 12, 967-977 (2013).
3. M. E. Davis, J. E. Zuckerman, C. H. J. Choi, D. Seligson, A. Tolcher, C. A. Alabi, Y. Yen, J. D. Heidel, A. Ribas, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067-1070 (2010).
4. J. C. Burnett, J. J. Rossi, K. Tiemann, Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol. J. 6, 1130-1146 (2011).
5. H. Yin, R. L. Kanasty, A. A. Eltoukhy, A. J. Vegas, J. R. Dorkin, D. G. Anderson, Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541-555 (2014).
6. K. T. Al-Jamal, L. Gherardini, G. Bardi, A. Nunes, C. Guo, C. Bussy, M. A. Herrero, A. Bianco, M. Prato, K. Kostarelos, T. Pizzorusso, Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc. Natl. Acad. Sci. U.S.A. 108, 10952-10957 (2011).
7. G. Bartholomeusz, P. Cherukuri, J. Kingston, L. Cognet, R. Lemos Jr., T. K. Leeuw, L. Gumbiner-Russo, R. B. Weisman, G. Powis, In vivo therapeutic silencing of hypoxia-inducible factor 1 alpha (HIF-1a) using single-walled carbon nanotubes noncovalently coated with siRNA. Nano Res. 2, 279-291 (2009).
8. D. A. Scheinberg, C. H. Villa, F. E. Escorcia, M. R. McDevitt, Conscripts of the infinite armada: Systemic cancer therapy using nanomaterials. Nat. Rev. Clin. Oncol. 7, 266-276 (2010).
9. M. R. McDevitt, D. Chattopadhyay, J. S. Jaggi, R. D. Finn, P. B. Zanzonico, C. Villa, D. Rey, J. Mendenhall, C. A. Batt, J. T. Njardarson, D. A. Scheinberg, PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PLOS One 2, e907 (2007).
10. A. Ruggiero, C. H. Villa, E. Bander, D. A. Rey, M. Bergkvist, C. A. Batt, K. Manova-Todorova, W. M. Deen, D. A. Scheinberg, M. R. McDevitt, Paradoxical glomerular filtration of carbon nanotubes. Proc. Natl. Acad. Sci. U.S.A. 107, 12369-12374 (2010).
11. J. J. Mulvey, C. H. Villa, M. R. McDevitt, F. E. Escorcia, E. Casey, D. A. Scheinberg, Selfassembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery. Nat. Nanotechnol. 8, 763-771 (2013).
12. M. R. McDevitt, D. Chattopadhyay, B. J. Kappel, J. S. Jaggi, S. R. Schiffman, C. Antczak, J. T. Njardarson, R. Brentjens, D. A. Scheinberg, Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J. Nucl. Med. 48, 1180-1189 (2007).
13. S. Alidori, K. Asqiriba, P. Londero, M. Bergkvist, M. Leona, D. A. Scheinberg, M. R. McDevitt, Deploying RNA and DNA with functionalized carbon nanotubes. J. Phys. Chem. C 117, 5982-5992 (2013).
14. C. A. Naughton, Drug-induced nephrotoxicity. Am. Fam. Physician 78, 743-750 (2008).
15. D. A. Ferenbach, J. V. Bonventre, Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat. Rev. Nephrol. 11, 264-276 (2015).
16. A. Zuk, J. V. Bonventre, D. Brown, K. S. Matlin, Polarity, integrin, and extracellular matrix dynamics in the postischemic rat kidney. Am. J. Physiol. 275, C711-C731 (1998).
17. R. L. Wolz, J. S. Bond, Meprins A and B. Methods Enzymol. 248, 325-345 (1995).
18. M. Jiang, Z. Dong, Regulation and pathological role of P53 in cisplatin nephrotoxicity. J. Pharmacol. Exp. Ther. 327, 300-307 (2008).
19. B. A. Molitoris, P. C. Dagher, R. M. Sandoval, S. B. Campos, H. Ashush, E. Fridman, A. Brafman, A. Faerman, S. J. Atkinson, J. D. Thompson, H. Kalinski, R. Skaliter, S. Erlich, E. Feinstein, siRNA targeted to P53 attenuates ischemic and cisplatin-induced acute kidney injury. J. Am. Soc. Nephrol. 20, 1754-1764 (2009).
20. H. E. Wang, P. Muntner, G. M. Chertow, D. G. Warnock, Acute kidney injury and mortality in hospitalized patients. Am. J. Nephrol. 35, 349-355 (2012).
21. J. S. Bond, G. L. Matters, S. Banerjee, R. E. Dusheck, Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer. FEBS Lett. 579, 3317-3322 (2005).
22. J.-M. V. Niyitegeka, A. C. Bastidas, R. H. Newman, S. S. Taylor, E. M. Ongeri, Isoform-specific interactions between meprin metalloproteases and the catalytic subunit of protein kinase A: Significance in acute and chronic kidney injury. Am. J. Physiol. Renal Physiol. 308, F56-F68 (2015).
23. C. Herzog, R. Seth, S. V. Shah, G. P. Kaushal, Role of meprin A in renal tubular epithelial cell injury. Kidney Int. 71, 1009-1018 (2007).
24. Z. Wang, C. Herzog, G. P. Kaushal, N. Gokden, P. R. Mayeux, Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis. Shock 35, 141-147 (2011).
25. G. P. Kaushal, R. S. Haun, C. Herzog, S. V. Shah, Meprin A metalloproteinase and its role in acute kidney injury. Am. J. Physiol. Renal Physiol. 304, F1150-F1158 (2013).
26. Q. Wei, G. Dong, T. Yang, J. Megyesi, P. M. Price, Z. Dong, Activation and involvement of P53 in cisplatin-induced nephrotoxicity. Am. J. Physiol. Renal Physiol. 293, F1282-F1291 (2007).
27. E. Hefner, K. Clark, C. Whitman, M. A. Behlke, S. D. Rose, A. S. Peek, T. Rubio, Increased potency and longevity of gene silencing using validated Dicer substrates. J. Biomol. Tech. 19, 231-237 (2008).
28. C. H. Villa, M. R. McDevitt, F. E. Escorcia, D. A. Rey, M. Bergkvist, C. A. Batt, D. A. Scheinberg, Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes. Nano Lett. 8, 4221-4228 (2008).
29. J. Gilleron, W. Querbes, A. Zeigerer, A. Borodovsky, G. Marsico, U. Schubert, K. Manygoats, S. Seifert, C. Andree, M. Stöter, H. Epstein-Barash, L. Zhang, V. Koteliansky, K. Fitzgerald, E. Fava, M. Bickle, Y. Kalaidzidis, A. Akinc, M. Maier, M. Zerial, Image-based analysis of lipid nanoparticle- mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638-646 (2013).
30. L. Rajendran, H.-J. Knölker, K. Simons, Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discov. 9, 29-42 (2010).
31. M. Okabe, M. Ikawa, K. Kominami, T. Nakanishi, Y. Nishimune, 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313-319 (1997).
32. S. Ishida, J. Lee, D. J. Thiele, I. Herskowitz, Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc. Natl. Acad. Sci. U.S.A. 99, 14298-14302 (2002).
33. M. Liu, C.-C. Chien, M. Burne-Taney, R. R. Molls, L. C. Racusen, R. B. Colvin, H. Rabb, A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J. Am. Soc. Nephrol. 17, 765-774 (2006).
34. L. H. Lu, D.-J. Oh, B. Dursun, Z. He, T. S. Hoke, S. Faubel, C. L. Edelstein, Increasedmacrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice. J. Pharmacol. Exp. Ther. 324, 111-117 (2008).
35. Y. Morishita, H. Yoshizawa, M. Watanabe, K. Ishibashi, S. Muto, E. Kusano, D. Nagata, siRNAs targeted to Smad4 prevent renal fibrosis in vivo. Sci. Rep. 4, 6424 (2014).
36. X. Zheng, X. Zhang, H. Sun, B. Feng, M. Li, G. Chen, C. Vladau, D. Chen, M. Suzuki, L. Min, W. Liu, R. Zhong, B. Garcia, A. Jevnikar, W.-P. Min, Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 82, 1781-1786 (2006).
37. A. Ozkok, C. L. Edelstein, Pathophysiology of cisplatin-induced acute kidney injury. BioMed. Res. Int. 2014, 967826 (2014).
38. N. Eliopoulos, J. Zhao, M. Bouchentouf, K. Forner, E. Birman, S. Yuan, M.-N. Boivin, D. Martineau, Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. Am. J. Physiol. Renal Physiol. 299, F1288-F1298 (2010).
39. S. Faubel, E. C. Lewis, L. Reznikov, D. Ljubanovic, T. S. Hoke, H. Somerset, D.-J. Oh, L. Lu, C. L. Klein, C. A. Dinarello, C. L. Edelstein, Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1b, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 322, 8-15 (2007).
40. B. J. Beattie, R. D. Finn, D. J. Rowland, K. S. Pentlow, Quantitative imaging of bromine-76 and yttrium-86 with PET: A method for the removal of spurious activity introduced by cascade gamma rays. Med. Phys. 30, 2410-2423 (2003).
41. J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, J.-Y. Tinevez, D. J. White, V. Hartenstein, K. Eliceiri, P. Tomancak, A. Cardona, Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676-682 (2012).